Drug intelligence / Profile preview

inactivated COVID-19 vaccine (Zhejiang Chinese Medical University)

Development stage: Unknown
Lead developer: Zhejiang Chinese Medical University
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

The inactivated COVID-19 vaccine (Zhejiang Chinese Medical University) refers to the vaccination intervention utilized in clinical research led by Zhejiang Chinese Medical University, specifically in the context of integrated traditional Chinese and western medicine. This research, exemplified by the multicenter study NCT05714306, evaluates the safety, immunogenicity, and preventive efficacy of inactivated SARS-CoV-2 vaccines in vulnerable populations, such as patients with autoimmune diseases. These vaccines are produced by chemically inactivating the SARS-CoV-2 virus, which allows the immune system to recognize and respond to viral antigens (including the spike and nucleocapsid proteins) without the risk of causing the disease. The university's research program aims to provide evidence-based support for the clinical value of combining these vaccines with traditional Chinese medicine (TCM) to optimize infection management and control disease activity in patients with underlying conditions.

Other names: inactivated COVID-19 vaccinesinactivated COVID-19 vaccines-Zhejiang Chinese Medical University-COVID-19

Beyond the preview

Go deeper on inactivated COVID-19 vaccine (Zhejiang Chinese Medical University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inactivated COVID-19 vaccine (Zhejiang Chinese Medical University).

Explore the full profile